Pfizer says its experimental COVID-19 pill cuts hospitalization, death risk by 89%
Pfizer says its experimental COVID-19 pill cuts hospitalization, death risk by 89%

Pfizer says its experimental pill for COVID-19 cuts the risk of hospitalization or death by nearly 90% in patients treated within three days of developing symptoms.